Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management.

Anaissie EJ, Mahfouz TH, Aslan T, Pouli A, Desikan R, Fassas A, Barlogie B.

Blood. 2004 Mar 1;103(5):1611-7. Epub 2003 Oct 2.

2.

Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy.

Aslan T, Fassas AB, Desikan R, Siegel D, Munshi N, Mehta J, Singhal S, Barlogie B, Anaissie E.

Bone Marrow Transplant. 1999 Sep;24(5):505-9. Review.

3.

Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia.

Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF.

Haematologica. 2007 Sep;92(9):1216-23. Epub 2007 Aug 1.

4.

Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.

Whimbey E, Champlin RE, Englund JA, Mirza NQ, Piedra PA, Goodrich JM, Przepiorka D, Luna MA, Morice RC, Neumann JL, et al.

Bone Marrow Transplant. 1995 Sep;16(3):393-9.

PMID:
8535312
5.

Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT.

Anak S, Atay D, Unuvar A, Garipardic M, Agaoglu L, Ozturk G, Karakas Z, Devecioglu O.

Pediatr Pulmonol. 2010 Mar;45(3):307-11. doi: 10.1002/ppul.21184.

PMID:
20146398
6.

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.

Liu V, Dhillon GS, Weill D.

Transpl Infect Dis. 2010 Feb;12(1):38-44. doi: 10.1111/j.1399-3062.2009.00453.x. Epub 2009 Sep 15.

PMID:
19761558
7.

[Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].

Kalayoglu Beşişik S, Sen F, Midilli K, Yilmaz G, Ozsüt H, Calangu S, Sargin D.

Mikrobiyol Bul. 2008 Apr;42(2):359-64. Turkish.

PMID:
18697436
8.

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.

Glanville AR, Scott AI, Morton JM, Aboyoun CL, Plit ML, Carter IW, Malouf MA.

J Heart Lung Transplant. 2005 Dec;24(12):2114-9. Epub 2005 Sep 6.

PMID:
16364859
9.

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.

Ghosh S, Champlin RE, Englund J, Giralt SA, Rolston K, Raad I, Jacobson K, Neumann J, Ippoliti C, Mallik S, Whimbey E.

Bone Marrow Transplant. 2000 Apr;25(7):751-5.

10.

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.

Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D, Weisser M, Gratwohl A, Fluckiger U, Hirsch HH.

Clin Infect Dis. 2008 Feb 1;46(3):402-12. doi: 10.1086/525263.

PMID:
18181739
11.

Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.

Avetisyan G, Mattsson J, Sparrelid E, Ljungman P.

Transplantation. 2009 Nov 27;88(10):1222-6. doi: 10.1097/TP.0b013e3181bb477e.

PMID:
19935377
12.

Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.

Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, Kontoyiannis D, Jacobson K, Luna M, Tarrand J, Whimbey E.

Bone Marrow Transplant. 2001 Aug;28(3):271-5.

13.

Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.

Wendt CH, Hertz MI.

Semin Respir Infect. 1995 Dec;10(4):224-31. Review.

PMID:
8668850
15.
16.

Management of infections caused by respiratory syncytial virus.

Swedish Consensus Group..

Scand J Infect Dis. 2001;33(5):323-8. Review.

PMID:
11440215
17.

Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.

Uçkay I, Gasche-Soccal PM, Kaiser L, Stern R, Mazza-Stalder J, Aubert JD, van Delden C.

J Heart Lung Transplant. 2010 Mar;29(3):299-305. doi: 10.1016/j.healun.2009.08.012. Epub 2009 Oct 17.

PMID:
19837611
18.

Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.

Flynn JD, Akers WS, Jones M, Stevkovic N, Waid T, Mullett T, Jahania S.

Pharmacotherapy. 2004 Jul;24(7):932-8. Review.

PMID:
15303457
19.

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.

Sparrelid E, Ljungman P, Ekelöf-Andström E, Aschan J, Ringdén O, Winiarski J, Wåhlin B, Andersson J.

Bone Marrow Transplant. 1997 May;19(9):905-8.

20.

Respiratory syncytial virus infection in adults.

Falsey AR.

Semin Respir Crit Care Med. 2007 Apr;28(2):171-81. Review.

PMID:
17458771

Supplemental Content

Support Center